Developer of a pharmacologic therapy designed to target orally dosed medicines, the key underlying neurobiological mechanisms that lead to airway obstruction. The company's therapeutics address the ph...

Healthcare
Cambridge, MA, United States
Founded 2017
83 employees
Website
Valuation
$440M
Latest known
Share Price
N/A
Total Raised
$259.3M
Last Round
N/A